ArticleJournal of neuro-oncology2024

The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab.

Pushan Dasgupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.